UBS Group’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $83M | Buy |
|
|||||
|
2021
Q1 | $49.2M | Buy |
|
|||||
|
2020
Q4 | $18.1M | Sell |
|
|||||
|
2020
Q3 | $100M | Buy |
|
|||||
|
2020
Q2 | $51.5M | Sell |
|
|||||
|
2020
Q1 | $59.8M | Sell |
|
|||||
|
2019
Q4 | $144M | Buy |
|
|||||
|
2019
Q3 | $57.6M | Buy |
|
|||||
|
2019
Q2 | $33.3M | Buy |
|
|||||
|
2019
Q1 | $32M | Sell |
|
|||||
|
2018
Q4 | $23.6M | Sell |
|
|||||
|
2018
Q3 | $51.8M | Buy |
|
|||||
|
2018
Q2 | $32.5M | Sell |
|
|||||
|
2018
Q1 | $70M | Sell |
|
|||||
|
2017
Q4 | $93.3M | Buy |
|
|||||
|
2017
Q3 | $64.6M | Buy |
|
|||||
|
2017
Q2 | $48.7M | Buy |
|
|||||
|
2017
Q1 | $7.02M | Sell |
|
|||||
|
2016
Q4 | $18.4M | Buy |
|
|||||
|
2016
Q3 | $6.49M | Sell |
|
|||||
|
2016
Q2 | $10.9M | Sell |
|
|||||
|
2016
Q1 | $13.5M | Sell |
|
|||||
|
2015
Q4 | $46.1M | Buy |
|
|||||
|
2015
Q3 | $16.6M | Sell |
|
|||||
|
2015
Q2 | $25.7M | Sell |
|
|||||
|
2015
Q1 | $36.8M | Sell |
|
|||||
|
2014
Q4 | $44.6M | Buy |
|